Association of virulent Helicobacter pylori strains with ischemic heart disease

Circulation

Volumn 97, Issue 17, 1998, Pages 1675-1679

  Pasceri, Vincenzo ^a   Cammarota, Giovanni ^a   Patti, Giuseppe ^a   Cuoco, Lucio ^a   Gasbarrini, Antonio ^a   Grillo, Rita L ^a   Fedeli, Giuseppe ^a   Gasbarrini, Giovanni ^a   Maseri, Attilio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Heart diseases; Helicobacter pylori; Risk factors

Indexed keywords

CYTOTOXIN; VIRULENCE FACTOR;

ACUTE HEART INFARCTION; ADULT; ANGINA PECTORIS; ARTICLE; ATHEROGENESIS; BACTERIAL GENE; BACTERIAL VIRULENCE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HELICOBACTER PYLORI; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL;

EID: 0032485913     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.17.1675     Document Type: Article

References (32)

1. Nieminen MS, Manila K, Valtonen V. Infection and inflammation as risk factors for myocardial infarction. Eur Heart J. 1993;14(suppl K):12-16.
2. Maseri A. Inflammation, atherosclerosis and ischemic events: exploring the hidden side of the moon. N Engl J Med. 1997;336:1014-1016.
3. Benditt EP, Barren T, McDougall JK. Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci U S A. 1983;80:6386-6389.
4. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Valtonen V. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2:983-986.
5. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet. 1996;348:567-572.
6. Manila KJ, Nieminen MS, Valtonen VV, Rasi VP, Kesaniemi YA, Syrjala SL, Jungell PS, Isoluoma M, Hietaniemi K, Jokinen MJ. Association between dental health and acute myocardial infarction. BMJ. 1989;298:779-781.
7. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J. 1994;71:437-439.
8. Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N, Levy J, Blakeston C, Seymour CA, Camm AJ, Northfield TC. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ. 1995;311: 711-714.
9. Murray LJ, Bamford KB, O'Reilly DPJ, McCrum EE, Evans AE. Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class. Br Heart J. 1995; 74:497-501.
10. Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease and stroke in middle aged men. Heart. 1996;75:568-572.
11. Niemelä S, Karttunen T, Korhonen T, Läärä E, Karttunen R, Ikäheimo M, Kesaniemi YA. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart. 1996;75:573-575.
12. Rathbone B, Martin D, Stephens J, Thompson JR, Samani NJ. Helicobacter pylori seropositivity in subjects with acute myocardial infarction. Heart. 1996;76:308-311.
13. Wald NJ, Law MR, Morris JK, Bagnall AM. Helicobacter pylori infection and mortality from ischemic heart disease: negative results from a large, prospective study. BMJ. 1997;315:1199-1201.
14. Logan RPH, Berg DE. Genetic diversity of Helicobacter pylori. Lancet. 1996;348:1462-1463.
15. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone A, Papini E, Xiang Z, Figura N. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A. 1993;90:5791-5795.
16. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995;55:2111-2115.
17. Peek RM Jr, Miller GG, Tham KT, Perez-Perez GI, Zhao X, Atherton JC, Blaser MJ. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest. 1995;73:760-770.
18. Ghiara P, Marchetti M, Blaser MJ, Tummure MK, Cover TL, Segal ED, Tompkins LS, Rappouli R. Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect Immun. 1995;63:4154-4160.
19. Wannamethe SG, Whincup PH, Shoper G, Walker M. Influence of fathers' social class on cardiovascular disease in middle-aged men. Lancet. 1996;348:1259-1263.
20. Ching CK, Wong BC, Kwok E, Ong L, Covacci A, Lam SK. Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls. Am J Gastroenterol. 1996;91:949-953.
21. Glantz SA, Shinken BK. Primer of Applied Regression and Analysis of Variance. New York, NY: McGraw Hill; 1990.
22. Weel JF, van der Hulst RW, Gerritis Y, Roorda P, Feller M, Dankert J, Tytgat GN, van der Ende A. The interrelationship between cytotoxin- associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis. 1996;173:1171-1175.
23. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in the male survivors of myocardial infarction. Circulation. 1997;96:404-407.
24. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994;331:417-424.
25. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB, for the ECAT study group. Production of C-reactive protein and the risk of coronary events in stable and unstable angina. Lancet. 1997;349:462-466.
26. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
27. Pober S, Cytokine-mediated activation of vascular endothelium. Am J Pathol. 1988;133:426-433.
28. Chooi CC, Callus AS. Acute phase reaction, fibrinogen level and thrombus size. Thromb Res. 1989;53:493-501.
29. Rasi V, Ikkala E, Valtonen V. Plasma beta-thromboglobulin in severe infections. Thromb Res. 1982;26:267-274.
30. Bhagat K, Moss R, Collier J, Vallance P. Endothelial "stunning" following a brief exposure to endotoxin: a mechanism to link infection and infarction? Cardiovasc Res. 1996;32:822-829.
31. Fan XG, Yakoob J, Chua A, Fan XJ, Keeling PW. Helicobacter pylori- induced lipid peroxidation in peripheral blood lymphocytes. APMIS. 1995;103:316-319.
32. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A. 1995;92:3893-3897.